Stockreport

Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]

Marker Therapeutics, Inc.  (MRKR) 
Last marker therapeutics, inc. earnings: 11/12 04:01 pm Check Earnings Report
PDF MT-601 demonstrated 66% objective response rate with 50% complete response in relapsed Non-Hodgkin lymphoma (NHL) patients in the ongoing APOLLO study First patient t [Read more]